Antibiotic resistant superbugs|New compound|TheHealthSite.com

A new study published in the journal ACS Nano, has discovered a new compound which can kill gram-negative E. coli, including a multidrug resistant pathogen said to be responsible for millions of antibiotic resistant infections worldwide annually.

By: IANS | | Updated: May 29, 2019 8:30 am

Antibiotic resistance happens when germs like bacteria and fungi develop the ability to defeat the drugs designed to kill them. ©Shutterstock

Researchers have discovered a new drug compound which kills antibiotic resistant gram-negative bacteria that can cause infections including pneumonia, urinary tract infections and bloodstream infections. Also Read - Antimicrobial resistance: What is it all about and ways to prevent it

Also Read - Candida auris: The deadly superbug that may become a global threat

The research, published in the journal ACS Nano, describes the new compound which kills gram-negative E. coli, including a multidrug resistant pathogen said to be responsible for millions of antibiotic resistant infections worldwide annually. Also Read - Ramizol antibiotic can tackle drug-resistant bacteria: Study

“As the compound is luminescent it glows when exposed to light. This means the uptake and effect on bacteria can be followed by the advanced microscope techniques available at RAL (Rutherford Appleton Laboratory in Britain),” said Jim Thomas, Professor at the University of Sheffield in Britain.

“This breakthrough could lead to vital new treatments to life-threatening superbugs and the growing risk posed by antimicrobial resistance,” Thomas added.

The studies at Sheffield and RAL have shown the compound seems to have several modes of action, making it more difficult for resistance to emerge in the bacteria.

In a recent report on antimicrobial resistant pathogens, the World Health Organisation put several gram-negative bacteria at the top of its list, stating that new treatments for these bacteria were “Priority 1 Critical” because they cause infections with high death rates, are rapidly becoming resistant to all present treatments and are often picked up in hospitals.

The next step of the research will be to test it against other multi-resistant bacteria.

Published : May 29, 2019 8:29 am | Updated:May 29, 2019 8:30 am

Read Disclaimer

Women with stomach cancer live longer than men patients: Study

AI detects new class of genetic mutations behind autism

About The health Site

TheHealthSite.com is India's largest health site with more than 40 lakh unique visitors per month. We focus on fitness, beauty, health, pregnancy and more.

Most popular health and wellness website in India in 2012 at the Website of the year awards.

health@corp.india.com

+91 – 22 – 6697 1234

91 – 22 – 2490 0302.

ZEE ENTERTAINMENT ENTERPRISES LTD, 18th floor, A-Wing, Marathon Futurex, N. M. Joshi Marg, Lower Parel, Mumbai, Maharashtra 400013.

We respect your privacy

Women with stomach cancer live longer than men patients: Study

AI detects new class of genetic mutations behind autism

Over one million STIs diagnosed every day: All you need to know about these infections

Antimicrobial resistance: What is it all about and ways to prevent it

Candida auris: The deadly superbug that may become a global threat

Cervical Cancer: Early detection, treatment crucial

About The health Site

Useful Links